Pfizer Inc. agreed to buy Arena Pharmaceuticals Inc. in a deal valued at about $6.7 billion, gaining potential therapies targeting immuno-inflammatory diseases. The U.S. drugmaker will pay $100 a share in an all-cash...
Alembic Pharma buys stake in US biotech RIGImmune
Alembic Pharma on Friday announced that it has made a strategic investment in RIGImmune, a biopharmaceutical research company co-founded by two prominent Yale University professors that’s focused on the...
Biopharma company Alvotech to go public in $2.25 bln SPAC deal
Biopharmaceutical company Alvotech Holdings SA said on Tuesday it plans to list in New York by merging with a blank-check company backed by Oaktree Capital Management, in a deal that values the combined entity at around...
Merck ties up with Thermo Fisher to make its COVID-19 pill in Canada
Drugmaker Merck & Co on Monday announced a deal with Thermo Fisher Scientific to manufacture its experimental COVID-19 pill at the medical device maker’s site in Whitby, Ontario. The site will manufacture the...
Odyssey buys drugmaker BenevolentAI in Europe’s biggest SPAC deal
Amsterdam-listed Odyssey has agreed to buy BenevolentAI in a deal valuing the British-based pharmaceuticals firm at up to 1.5 billion euros after the transaction, the biggest acquisition by a European special purpose...
UK pharma services firm Clinigen gets possible takeover proposal
UK’s Clinigen said on Thursday it received a possible takeover proposal from UK-based private equity firm Triton Investment Management, sending shares of the British pharmaceutical services firm soaring 15%. The...
Encube Ethicals to buy Soframycin for Rs 125 crore for India & SL markets
Encube Ethicals on Friday said it has agreed to buy popular topical anti-microbial brand Soframycin and other brands from French drugmaker Sanofi for India and Sri Lanka markets for Rs 125 crore. Along with Soframycin...
Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
The board of Ipca Labs has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs Limited and entering into a joint management control agreement with the promoters of Lyka Labs. Ipca said it has...
Sweden’s Karo Pharma to buy Sylphar in $326 million deal
Specialty pharma group Karo Pharma has agreed to buy Belgium-based Sylphar International from Vendis Capital and Sylphar’s founder for 290 million euros ($326 million), it said on Tuesday. Karo Pharma said...
GSK ties up with Arrowhead to develop NASH drug candidate
Arrowhead Pharmaceuticals Inc (ARWR.O) on Monday entered a drug development deal with GlaxoSmithKline Plc (GSK.L) under which the British drugmaker will develop and market Arrowhead’s potential treatment for...
Ind-Swift in talks with PE companies to sell stake
Pharmaceutical company Ind-Swift Laboratories is engaged in talks with private equity investors to sell a large minority stake, after it failed to complete the sale process with PI Industries. A clutch of private equity...
France’s Abionyx to buy IRIS Pharma Holding, expand into ophthalmology
French biopharmaceutical company Abionyx Pharma said on Wednesday it had signed a deal to buy the owner of the ophthalmological group IRIS Pharma. Abionyx said it would fully finance the deal, which values IRIS Pharma...
